Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
NEXI-001
i
Other names:
NEXI-001
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
NexImmune
Drug class:
Wilms tumor 1 inhibitor, PRAME inhibitor, CD8 T-cell agonist, INCA inhibitor
Related drugs:
‹
galinpepimut-S (3)
INO-5401 (1)
ASP7517 (0)
ATA520 (0)
Allo WT1-TCR (0)
CMD-602 (0)
CUE-102 (0)
CVT-DC-01 (0)
EU210 (0)
MANA-312 (0)
RG6007 (0)
WT2725 (0)
DSP-7888 (0)
p.DOM-WT1-126 DNA vaccine (0)
IMC-F106C (2)
BPX-701 (0)
IMA203 (0)
IMA203CD8 (0)
IMA402 (0)
MDG1011 (0)
MultiTAA T cell therapy (0)
multiplexed MAGEA1/PRAME TCR-T cell therapy (0)
ADP-A2M4CD8 (1)
AB248 (0)
AB821 (0)
EU204 (0)
Human tyrosinase DNA Vaccine (0)
IL-15 DC (0)
LB4330 (0)
NEXI-002 (0)
NEXI-003 (0)
SLC-3010 (0)
rhIL-15 (0)
galinpepimut-S (3)
INO-5401 (1)
ASP7517 (0)
ATA520 (0)
Allo WT1-TCR (0)
CMD-602 (0)
CUE-102 (0)
CVT-DC-01 (0)
EU210 (0)
MANA-312 (0)
RG6007 (0)
WT2725 (0)
DSP-7888 (0)
p.DOM-WT1-126 DNA vaccine (0)
IMC-F106C (2)
BPX-701 (0)
IMA203 (0)
IMA203CD8 (0)
IMA402 (0)
MDG1011 (0)
MultiTAA T cell therapy (0)
multiplexed MAGEA1/PRAME TCR-T cell therapy (0)
ADP-A2M4CD8 (1)
AB248 (0)
AB821 (0)
EU204 (0)
Human tyrosinase DNA Vaccine (0)
IL-15 DC (0)
LB4330 (0)
NEXI-002 (0)
NEXI-003 (0)
SLC-3010 (0)
rhIL-15 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login